These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 13678561)

  • 1. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury.
    Arciniegas DB
    Curr Psychiatry Rep; 2003 Oct; 5(5):391-9. PubMed ID: 13678561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation.
    Arciniegas D; Adler L; Topkoff J; Cawthra E; Filley CM; Reite M
    Brain Inj; 1999 Jan; 13(1):1-13. PubMed ID: 9972437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link?].
    Bennouna M; Greene VB; Defranoux L
    Encephale; 2007 Sep; 33(4 Pt 1):616-20. PubMed ID: 18033152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.
    Dumas JA; Newhouse PA
    Pharmacol Biochem Behav; 2011 Aug; 99(2):254-61. PubMed ID: 21382398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 1: the structure and function of cerebral cholinergic systems.
    Arciniegas DB
    J Head Trauma Rehabil; 2011; 26(1):98-101. PubMed ID: 21209567
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers of cognitive dysfunction in traumatic brain injury.
    Sun ZL; Feng DF
    J Neural Transm (Vienna); 2014 Jan; 121(1):79-90. PubMed ID: 23942913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour.
    Steckler T; Sahgal A
    Behav Brain Res; 1995 Mar; 67(2):165-99. PubMed ID: 7779290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of posttraumatic cognitive impairments.
    Arciniegas DB; Silver JM
    Behav Neurol; 2006; 17(1):25-42. PubMed ID: 16720958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion.
    Xi Y; Wang M; Zhang W; Bai M; Du Y; Zhang Z; Li Z; Miao J
    Neurobiol Learn Mem; 2014 Mar; 109():7-19. PubMed ID: 24315928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury.
    Arciniegas DB; Topkoff JL
    Phys Med Rehabil Clin N Am; 2004 Feb; 15(1):177-203, viii. PubMed ID: 15029905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic markers of cholinergic function in the rat brain: relationship with age and cognitive status.
    Baxter MG; Frick KM; Price DL; Breckler SJ; Markowska AL; Gorman LK
    Neuroscience; 1999 Mar; 89(3):771-9. PubMed ID: 10199612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction.
    Schliebs R; Rossner S; Bigl V
    Prog Brain Res; 1996; 109():253-64. PubMed ID: 9009714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat.
    Dixon CE; Liu SJ; Jenkins LW; Bhattachargee M; Whitson JS; Yang K; Hayes RL
    Behav Brain Res; 1995 Oct; 70(2):125-31. PubMed ID: 8561903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 2: evidence from basic and clinical investigations.
    Arciniegas DB
    J Head Trauma Rehabil; 2011; 26(4):319-23. PubMed ID: 21734513
    [No Abstract]   [Full Text] [Related]  

  • 15. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.
    Lawrence AD; Sahakian BJ
    Neurochem Res; 1998 May; 23(5):787-94. PubMed ID: 9566619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury.
    Reid WM; Hamm RJ
    J Neurotrauma; 2008 Mar; 25(3):248-56. PubMed ID: 18352838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic neurons of the central nervous system: morphofunctional aspects.
    Bigl V; Arendt T
    Acta Psychiatr Scand Suppl; 1991; 366():7-13. PubMed ID: 1654729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction.
    Verbois SL; Hopkins DM; Scheff SW; Pauly JR
    Neuroscience; 2003; 119(4):1199-208. PubMed ID: 12831873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-induced recovery of cognitive function after diffuse and focal brain damage: implications for neural transplantation in man.
    Hodges H
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(1):29-58. PubMed ID: 7754697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modes and models of forebrain cholinergic neuromodulation of cognition.
    Hasselmo ME; Sarter M
    Neuropsychopharmacology; 2011 Jan; 36(1):52-73. PubMed ID: 20668433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.